Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q3 2025 Earnings

31JulConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-18.38

-15.13

-11.87

-8.62

Details

Expected EPS

-10.25852742512

Actual EPS

-9.6225168

Surprise EPS

0.64

Surprise Percent

+6.2%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -9.6225168 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.